Shares in Novartis (NYSE:NVS) were up today after the company beat expectations on Wall Street with its second-quarter financial results.
The Switzerland-based company posted profits of $7.77 billion, or $3.34 per share, on sales of $13.16 billion for the three months ended June 30. Novartis saw its quarterly sales climb 7% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Novartis posts Q2 beat, promises to hold off on drug price hikes appeared first on MassDevice.
from MassDevice https://ift.tt/2uGyywE
Cap comentari:
Publica un comentari a l'entrada